NCT04708860View on ClinicalTrials.gov

Feasibility of Fasting & Exercise in Pts With HR+ MBC

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

July 31, 2024

Conditions
Breast CancerMetastatic Breast Cancer
Interventions
BEHAVIORAL

Prolonged Nightly Fasting

Restriction of consumption of calorie-containing food/drinks after 8pm

BEHAVIORAL

Exercise

Personalized moderate-intensity, aerobic exercise and strength training

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT04708860 - Feasibility of Fasting & Exercise in Pts With HR+ MBC | Biotech Hunter | Biotech Hunter